Financials BrightSpring Health Services, Inc.

Equities

BTSG

US10950A1060

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
11.4 USD -1.98% Intraday chart for BrightSpring Health Services, Inc. -0.96% 0.00%

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 1,953 - -
Enterprise Value (EV) 1 4,277 4,149 3,920
P/E ratio 14.3 x 11.2 x 9.3 x
Yield - - -
Capitalization / Revenue 0.18 x 0.17 x 0.16 x
EV / Revenue 0.4 x 0.37 x 0.32 x
EV / EBITDA 7.58 x 6.75 x 5.88 x
EV / FCF 21.6 x 17.8 x -
FCF Yield 4.63% 5.63% -
Price to Book 1.25 x 1.11 x 0.97 x
Nbr of stocks (in thousands) 171,320 - -
Reference price 2 11.40 11.40 11.40
Announcement Date - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 8,826 10,609 11,308 12,301
EBITDA 1 - 537.8 564.4 614.8 666.8
EBIT 1 - 335.5 355.5 377 426.1
Operating Margin - 3.8% 3.35% 3.33% 3.46%
Earnings before Tax (EBT) 1 - -177.4 146.6 194.5 248.6
Net income 1 -53.91 -154.6 147.9 217 279.2
Net margin - -1.75% 1.39% 1.92% 2.27%
EPS 2 -7.180 -1.310 0.7996 1.014 1.226
Free Cash Flow 1 - 137.3 197.9 233.6 -
FCF margin - 1.56% 1.87% 2.07% -
FCF Conversion (EBITDA) - 25.52% 35.07% 38% -
FCF Conversion (Net income) - - 133.83% 107.69% -
Dividend per Share 2 - - - - -
Announcement Date 8/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,375 2,577 2,616 2,656 2,759 2,786 2,834
EBITDA 1 142.6 130.5 144.5 139.3 149.6 143 157.2
EBIT 1 91.59 81.58 94.05 84.3 90.66 87.72 89.57
Operating Margin 3.86% 3.17% 3.6% 3.17% 3.29% 3.15% 3.16%
Earnings before Tax (EBT) -14.79 - - - - - -
Net income 1 -6.537 -45.75 45.69 44.57 53.46 63.42 68.27
Net margin -0.28% -1.78% 1.75% 1.68% 1.94% 2.28% 2.41%
EPS 2 -0.0600 -0.2600 0.2165 0.2156 0.2596 0.3054 0.3282
Dividend per Share 2 - - - - - - -
Announcement Date 2/29/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 3,385 2,324 2,196 1,966
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 6.294 x 4.118 x 3.571 x 2.949 x
Free Cash Flow 1 - 137 198 234 -
ROE (net income / shareholders' equity) - 1.77% 9.75% 9.01% 9.71%
ROA (Net income/ Total Assets) - 0.22% 5.72% 6.4% 6.57%
Assets 1 - -71,609 2,583 3,392 4,249
Book Value Per Share 2 - 4.960 9.090 10.20 11.70
Cash Flow per Share 2 - 1.790 0.4000 1.740 2.210
Capex 1 - 73.5 78 91.8 94.5
Capex / Sales - 0.83% 0.73% 0.81% 0.77%
Announcement Date 8/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
11.4 USD
Average target price
16.23 USD
Spread / Average Target
+42.34%
Consensus
  1. Stock Market
  2. Equities
  3. BTSG Stock
  4. Financials BrightSpring Health Services, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW